Skip to content

Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation

Multi Center Clinical Observation of Sentinel Skin Graft From the Same Donor Source for Detecting Acute Rejection After Renal Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05600634
Enrollment
24
Registered
2022-10-31
Start date
2024-01-01
Completion date
2026-12-31
Last updated
2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant Rejection, Skin Graft

Brief summary

The purpose of this study was to explore the accuracy of sentinel skin grafts from the same donor source in diagnosing renal allograft rejection, and to provide new ideas and options for the later clinical diagnosis of renal allograft rejection. Further, try to provide timing guidance for early immunization intervention.

Interventions

PROCEDURESkin allotransplantation

Sentinel skin grafts from the same donor source will be carried on in the meantime of kidney transplantation for assisting to detect acute renal rejection.

Sponsors

Zhejiang University
CollaboratorOTHER
Sir Run Run Shaw Hospital
CollaboratorOTHER
The First Affiliated Hospital of Air Force Medicial University
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with end-stage renal disease undergoing renal transplantation; 2. 18-60 years old; 3. Postoperative follow-up points are complete (visit the hospital every week in the first month after surgery, every two weeks in 2-3 months, every four to six months, and every three months in 7-12 months. Follow up at any time when skin rejection is observed. The follow-up time may be adjusted when the condition changes); 4. The participants had good compliance, volunteered to participate in the test and signed the informed consent form.

Exclusion criteria

1. Untreated or disseminated malignant tumor; 2. Active period of infectious diseases; 3. Serious cardiovascular disease occurred recently; 4. Combined with other important organ failure; 5. History of mental illness or cognitive impairment;

Design outcomes

Primary

MeasureTime frameDescription
2017 Banff Kidney Transplantation Rejection RatingThrough study completion, an average of 1 yearA rating evaluation on kidney rejection
2007-edition Banff skin containing allogeneic composite histopathological diagnosis gradingThrough study completion, an average of 1 yearSkin histopathological diagnosis
Renal function testingThrough study completion, an average of 1 yearBlood Cr and Bun testing

Secondary

MeasureTime frameDescription
Renal ultrasound diagnosisThrough study completion, an average of 1 yearRenal ultrasound diagnosis
ComplicationsThrough study completion, an average of 1 yearComplications assessment

Countries

China

Contacts

Primary ContactChenggang Yi, M.D.
cwar@163.com+8613567113534
Backup ContactSongxue Guo, M.D.
guosongxue@zju.edu.cn+8618506857388

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026